Ophthalmology Doctors in Rome, GA Accepting Medicare

8 Ophthalmology doctors found. Showing 1 - 8

Dr. David Joseph Herren, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 550 Redmond Rd Nw, Rome, GA 30165 Phone: 706-233-8502

Dr. Dimple Modi, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 550 Redmond Rd Nw, Rome, GA 30165 Phone: 762-235-3200    Fax: 706-233-8503

Paul James Harton Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 550 Redmond Rd Nw, Rome, GA 30165 Phone: 706-233-8502    Fax: 706-233-8503

P. Carl Davidson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 109 John Maddox Dr Nw Ste 230, Rome, GA 30165 Phone: 706-291-7360

Robert Lester Harbin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 550 Redmond Rd Nw, Rome, GA 30165 Phone: 706-233-8502    Fax: 706-233-8503

Dr. Emmett Price Cordle, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2110 Shorter Ave Nw, Rome, GA 30165 Phone: 706-290-0098    Fax: 706-290-0941

Mr. Lawrence Michael Arkin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 105 John Maddox Drive, Rome, GA 30165 Phone: 706-290-0090    Fax: 706-290-1530

Britton Bayles Carter, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 550 Redmond Rd Nw, Rome, GA 30165 Phone: 762-235-3200    Fax: 706-233-8503

News Archive

The protein that makes you mad

In recent years our feeding habits have been the focus of ongoing polemics. Everybody will remember the "mad cow" crisis.

States examine costs of health law's Medicaid expansion detailed in new report

Reuters examines how Medicaid expansion might affect various states, with new findings from the Kaiser Commission on Medicaid and the Uninsured: "Under conservative estimates, Maine's Medicaid spending will decrease 1.5 percent and Colorado's will slip 0.5 percent, according to the study.

Third-quarter 2009 financial results announced by Halozyme Therapeutics

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009.

Researchers stimulate the body to repair tissue damaged by peripheral arterial obstructive disease

Duke University Medical Center researchers have shown that they can stimulate the body to produce its own naturally occurring growth factors to promote blood vessel growth into tissue damaged by peripheral arterial obstructive disease (PAOD).

Read more Medical News

› Verified 6 days ago